BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 12684918)

  • 1. Clinical course and prognostic factors of progressive multifocal leukoencephalopathy in patients treated with highly active antiretroviral therapy.
    Berenguer J; Miralles P; Arrizabalaga J; Ribera E; Dronda F; Baraia-Etxaburu J; Domingo P; Márquez M; Rodriguez-Arrondo FJ; Laguna F; Rubio R; Lacruz Rodrigo J; Mallolas J; de Miguel V;
    Clin Infect Dis; 2003 Apr; 36(8):1047-52. PubMed ID: 12684918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence and outcome of progressive multifocal leukoencephalopathy over 20 years of the Swiss HIV Cohort Study.
    Khanna N; Elzi L; Mueller NJ; Garzoni C; Cavassini M; Fux CA; Vernazza P; Bernasconi E; Battegay M; Hirsch HH;
    Clin Infect Dis; 2009 May; 48(10):1459-66. PubMed ID: 19348592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of JC virus DNA levels in cerebrospinal fluid of patients with HIV-associated progressive multifocal leukoencephalopathy.
    Bossolasco S; Calori G; Moretti F; Boschini A; Bertelli D; Mena M; Gerevini S; Bestetti A; Pedale R; Sala S; Sala S; Lazzarin A; Cinque P
    Clin Infect Dis; 2005 Mar; 40(5):738-44. PubMed ID: 15714422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD4+ cell count 6 years after commencement of highly active antiretroviral therapy in persons with sustained virologic suppression.
    Moore RD; Keruly JC
    Clin Infect Dis; 2007 Feb; 44(3):441-6. PubMed ID: 17205456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delayed progression to death and to AIDS in a Hong Kong cohort of patients with advanced HIV type 1 disease during the era of highly active antiretroviral therapy.
    Wong KH; Chan KC; Lee SS
    Clin Infect Dis; 2004 Sep; 39(6):853-60. PubMed ID: 15472819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Progressive multifocal leukoencephalopathy in patients with AIDS: is there a change in patients treated with highly active antiretroviral therapies?].
    Montes Santiago J; Pérez Fernández E; González Vázquez L; Morano Amado L; Fernández Martín J; Asorey Carballeira A; Pérez Alvarez R
    An Med Interna; 2002 May; 19(5):230-3. PubMed ID: 12107996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Acquired immunodeficiency syndrome-associated progressive multifocal leukoencephalopathy treated with highly active anti-retroviral therapy].
    Shimizu Y; Ota K; Takeuchi M; Iwata M; Yogo Y
    Rinsho Shinkeigaku; 2000 Aug; 40(8):821-6. PubMed ID: 11218704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term survival of HIV-infected patients treated with highly active antiretroviral therapy in Serbia and Montenegro.
    Jevtović DO; Salemović D; Ranin J; Pesić I; Zerjav S; Djurković-Djaković O
    HIV Med; 2007 Mar; 8(2):75-9. PubMed ID: 17352762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progressive multifocal leukoencephalopathy in patients with AIDS receiving highly active antiretroviral therapy.
    Tantisiriwat W; Tebas P; Clifford DB; Powderly WG; Fichtenbaum CJ
    Clin Infect Dis; 1999 May; 28(5):1152-4. PubMed ID: 10452651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Central nervous system immune reconstitution disease in acquired immunodeficiency syndrome patients receiving highly active antiretroviral treatment.
    Gray F; Bazille C; Adle-Biassette H; Mikol J; Moulignier A; Scaravilli F
    J Neurovirol; 2005; 11 Suppl 3():16-22. PubMed ID: 16540449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive factors for prolonged survival in acquired immunodeficiency syndrome-associated progressive multifocal leukoencephalopathy.
    Berger JR; Levy RM; Flomenhoft D; Dobbs M
    Ann Neurol; 1998 Sep; 44(3):341-9. PubMed ID: 9749600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinants of clinical progression in antiretroviral-naive HIV-infected patients starting highly active antiretroviral therapy. Aquitaine Cohort, France, 1996-2002.
    Bonnet F; Thiébaut R; Chêne G; Neau D; Pellegrin JL; Mercié P; Beylot J; Dabis F; Salamon R; Morlat P;
    HIV Med; 2005 May; 6(3):198-205. PubMed ID: 15876287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolution of purely infratentorial PML under HAART--negative outcome under rapid immune reconstitution.
    Kastrup O; Wanke I; Esser S; Maschke M
    Clin Neurol Neurosurg; 2005 Oct; 107(6):509-13. PubMed ID: 16202824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Case of highly active anti-retroviral therapy-induced immune reconstitution inflammatory syndrome in AIDS-related progressive multifocal leukoencephalopathy].
    Imamura E; Yamashita H; Fukuhara T; Sawa H; Nagashima K; Kuwabara M; Tokinobu H
    Rinsho Shinkeigaku; 2007 Oct; 47(10):650-6. PubMed ID: 18095498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical outcomes and immune reconstitution in 103 advanced AIDS patients undergoing 12-month highly active antiretroviral therapy.
    Dai Y; Qiu ZF; Li TS; Han Y; Zuo LY; Xie J; Ma XJ; Liu ZY; Wang AX
    Chin Med J (Engl); 2006 Oct; 119(20):1677-82. PubMed ID: 17097013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mortality in HIV-seropositive versus -seronegative persons in the era of highly active antiretroviral therapy: implications for when to initiate therapy.
    Wang C; Vlahov D; Galai N; Bareta J; Strathdee SA; Nelson KE; Sterling TR
    J Infect Dis; 2004 Sep; 190(6):1046-54. PubMed ID: 15319852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progressive multifocal leukoencephalopathy--as a presenting manifestation of AIDS.
    Raina S; Kaushal SS; Gupta D; Himral P; Sawal N; Sood V; Goyal A
    J Assoc Physicians India; 2007 Nov; 55():797-801. PubMed ID: 18290557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fulminant inflammatory leukoencephalopathy associated with HAART-induced immune restoration in AIDS-related progressive multifocal leukoencephalopathy.
    Vendrely A; Bienvenu B; Gasnault J; Thiebault JB; Salmon D; Gray F
    Acta Neuropathol; 2005 Apr; 109(4):449-55. PubMed ID: 15739098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fatal immune restoration disease in human immunodeficiency virus type 1-infected patients with progressive multifocal leukoencephalopathy: impact of antiretroviral therapy-associated immune reconstitution.
    Safdar A; Rubocki RJ; Horvath JA; Narayan KK; Waldron RL
    Clin Infect Dis; 2002 Nov; 35(10):1250-7. PubMed ID: 12410486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in the natural history of progressive multifocal leukoencephalopathy in HIV-negative lymphoproliferative disorders: impact of novel therapies.
    García-Suárez J; de Miguel D; Krsnik I; Bañas H; Arribas I; Burgaleta C
    Am J Hematol; 2005 Dec; 80(4):271-81. PubMed ID: 16315252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.